05/28/2026
Progress continues for our Nu.Q® NETs assay, with inclusion in the DETECSEPS program, a government-backed initiative in France focused on improving early sepsis detection and enabling more personalized patient care.
We also announced two additional potential clinical applications beyond sepsis: acute trauma care and Hidradenitis Suppurativa (HS). Together, these emerging use cases highlight the broad potential of Nu.Q® NETs across both acute and chronic disease settings.
Learn more: tinyurl.com/ytzdepxk